escalation of cocaine intake under conditions of extended access to the drug (Mantsch & Katz, [ 32] ). Stressinduced reinstatement of extinguished drug-seeking behavior requires corticosterone (Erb et al., [ 16] ; Mantsch & Goeders, [ 31] ), although elevations in the hormone alone may not be sufficient to cause reinstatement (Lee et al., [ 28] ; Graf et al., [ 21] ; but see Deroche et al., [15] ). Previous studies indicate that the impact of stress on drug-seeking behavior is, in part, due to the effects of corticosterone on dopamine (DA) signaling in rewardprocessing circuitry. Specifically, corticosterone augments cocaine's ability to increase DA concentration in the nucleus accumbens (NAc), potentiating cocaine-induced locomotor activity and cocaine-induced reinstatement of drug seeking (Rouge-Pont et al., [ 43] ; Graf et al., [ 21] ). In our studies, corticosterone potentiated cocaineprimed reinstatement both when the steroid was administered systemically and when it was directly infused into the NAc, demonstrating that corticosterone acts locally in the NAc to modulate drug seeking behavior (Graf et al., [ 21] ).
In addition to its effects on cocaine seeking, stress also influences the processing of natural rewards, potentially through similar physiological pathways (Reynolds & Berridge, [ 41] ; Volkow et al., [ 54] ; Berridge, [ 4] ). Stress can cause overeating, particularly of palatable foods, in both laboratory animals and overweight people (Rowland & Antelman, [ 44] ; Dallman, [ 13] ). As with cocaine, behavioral and dopaminergic responses to natural rewards are modulated by glucocorticoids. Adrenalectomized rats exhibit reduced consumption of natural gustatory rewards, and regular levels of consumption are restored by corticosterone supplement (Bell et al., [ 3] ; Bhatnagar et al., [ 6] ). Furthermore, exogenous glucocorticoid administration causes overeating and weight gain (Tataranni et al., [ 50] ). The influence of corticosterone on natural reward processing likely cooccurs with an increase in DA levels in the NAc in response to palatable foods. Corticosterone facilitates DA signaling in the NAc (Barrot et al., [ 2] ), and rats will readily self-administer corticosterone itself, the consumption of which increases DA, particularly during feeding (Piazza et al., [ 39] ).
The notion that stress and glucocorticoids may contribute to both obesity and addiction through a common dopaminergic mechanism is intriguing (Volkow et al., [ 54] ). Using fast-scan cyclic voltammetry in behaving rats, we examined the effects of corticosterone on subsecond DA signaling in the NAc to determine: (i) the specific components of spontaneous DA signals altered by corticosterone alone, (ii) the effects of corticosterone on DA signaling after cocaine administration, and (iii) the effects of corticosterone on DA signals in response to a natural reward. Scrutinizing individual characteristics of spontaneous dopamine release events (i.e. transients) can reveal a selective influence on extracellular DA signaling, and potentially suggest corticosterone's mechanism of action. The frequency of observed transients reflects DA release frequency, a factor that is dictated by the burst firing of DA neurons. Peak transient amplitude is sensitive to factors that influence both release and clearance, and transient duration (as measured by half-width) is affected by changes in DA clearance (Wightman et al., [ 58] ; Cragg & Rice, [ 12] ; Aragona et al., [ 1] ). For example, several reinforcing drugs (e.g. nicotine, ethanol, and cocaine) increase dopamine concentration, but of these, only cocaine increases transient duration, indicative of its actions blocking the dopamine transporter (Cheer et al., [ 8] ). The following findings indicate that corticosterone preferentially affects DA uptake and is more influential in situations in which the DA transporter is blocked by cocaine.
Methods

Subjects
Male Sprague-Dawley rats (Envigo) weighing 275-300 g were individually housed in a temperature and humidity controlled AAALAC-accredited vivarium. Rats were maintained on a 12/12 reversed dark/light cycle, and all experimental procedures were conducted during the dark phase (starting at 0700 hours) to more closely approximate the procedures of Graf et al. ([ 21] ). All experimental protocols were approved by the Institutional Animal Care and Use Committee at Marquette University in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Seventeen (10 corticosterone and seven vehicle treated) rats were used in the cocaine experiment, and five naïve rats were used in the saccharin experiment.
Surgical procedures
All surgical procedures were conducted under ketamine/xylazine (100 mg/kg; 20 mg/kg, i.p.) anesthesia. A 1-mm diameter electrode guide cannula (BASi) was implanted above the NAc core (AP: +1.3; ML: ± 1.3) or NAc shell (AP: +1.7; ML: ± 0.8) unilaterally, and a Ag/AgCl reference electrode was placed contralateral to the guide cannula. For the saccharin experiment, a single intraoral catheter was implanted as previously described (Wheeler et al., [ 55] ). For all surgical procedures, rats were treated with the anti-inflammatory meloxicam (1% oral suspension) the day of, and for 4 days following surgery to reduce inflammation and postoperative pain.
Apparatus
Both experiments were conducted in a standard operant chamber (Med Associates), interfaced with a computer, and housed in sound attenuating Faraday cages. The operant chamber had a dedicated syringe pump for intraoral infusions of saccharin sodium salt (0.15% based on the weight of the salt; Sigma) that were delivered to each rat via a single-channel fluid swivel (Instech Laboratories). The chamber floor was clear acrylic glass, and illumination was provided by a house light positioned on the door of the sound-attenuating chamber. Rats were harnessed to a rotating commutator (Crist Instruments) for electrochemical recordings. Corticosterone (1 mg/mL; Sigma) was dissolved in a 90% saline and 10% ethanol vehicle solution (Spencer & Deak, [ 48] ). Cocaine HCl (NIDA; 8.25 mg/mL based on the weight of the salt) was dissolved in a saline vehicle.
Cocaine experiment
On a day prior to DA measurements, subjects were habituated to the recording environment for approximately 1 h. The experiment consisted of DA measurements during a 30-min baseline phase, a 40-min corticosterone or vehicle phase, and a 40-min cocaine phase (see Fig. [NaN] ). Corticosterone (2.0 mg/kg i.p.) and cocaine (2.5 mg/kg i.p.) were administered immediately before their respective recording phases. This dose of corticosterone produces a plasma corticosterone level similar to that produced by an acute stressor (Graf et al., [ 21] ). The low dose of cocaine was specifically chosen because it does not produce reinstatement of cocaine seeking when administered alone, but does cause reinstatement when administered with corticosterone (Graf et al., [ 21] ). Before each experiment, a carbon fiber electrode was lowered into the NAc. The fiber was held at −0.4 V between scans and then driven to +1.3 V and back in a triangular fashion at 400 V/s for each voltammetric measurement. The application of this triangle waveform causes oxidation and reduction in chemical species that are electroactive within this potential range, producing a change in current at the carbonfiber. Specific analytes (including DA and pH) are identified by plotting these changes in current against the applied potential to produce a cyclic voltammogram (Heien et al., [ 22] , [ 23] ). The current arising from electrode processes was removed using background subtraction. Recordings were blocked into 30-s bins, and the background period was taken as the nadir during each bin. This practice does not subtract the presence of spontaneous DA release events because the background was explicitly selected for the absence of DA signals. Measurements were made every 100 ms and, after driving the electrode into the NAc, the electrode equilibrated for 40 min before any data were collected. Because the present experiment required an analysis of naturally occurring DA signaling, the dorsoventral position of the microelectrode was optimized by monitoring the presence of spontaneously occurring DA release events (Wightman et al., [ 59] ; Roitman et al., [ 42] ; Wheeler et al., [ 56] ; Twining et al., [ 51] ). Once this was observed, the electrode was locked in place and data collection proceeded.
Analyte identification and quantification were achieved using a principal component regression analysis described in detail elsewhere (Heien et al., [ 22] ). All data presented here fit the resulting model at the 95% confidence level. Briefly, training sets were generated from background-subtracted cyclic voltammograms collected during and after electrical stimulations. DA was isolated with a chemometric analysis using a previously recorded training set (Twining et al., [ 51] ; Wheeler et al., [ 57] ) matched for oxidation potential and transient amplitude. The resulting current amplitude was converted to DA concentration based on the average postexperiment electrode sensitivity (Wheeler et al., [ 57] ). Transient analysis was adapted from Vander Weele et al.
( [ 53] ). Transients were identified with MATLAB (code provided by Dr. Richard Keithley) and characterized with Mini Analysis (Synaptosoft). Transients were defined as DA fluctuations that exceeded 20 nm, lasted at least 200 ms, and were at least five times greater than the root-mean-square noise sampled during a 2-s period in each trial.
Saccharin experiment
Because the DA response to saccharin is variable between subjects and brief relative to the effects of cocaine, a purely within-subjects design was employed to maximize sensitivity to any potential effect of corticosterone. Furthermore, all recordings were made in the NAc shell because DA signaling in this subregion is more sensitive to primary rewarding or aversive stimuli (Wheeler et al., [ 56] ). On a day prior to DA measurements, subjects were habituated to the recording environment for approximately 1 h. During the habituation session, all subjects received 30 intraoral infusions of a 0.15% saccharin solution (0.2 mL over 15 s) to reduce any neophobia during the experiment. The experiment consisted of DA measurements during a 30-min pre-corticosterone saccharin phase, a 40-min corticosterone phase, and a 30-min post-corticosterone saccharin phase (see Fig. [NaN] A). Subjects received 30 intraoral infusions during each saccharin phase. DA measurements were acquired and isolated as in the cocaine experiment. In order to assess the phasic response to saccharin before and after corticosterone administration, each trial was divided into a 10-s pre-infusion baseline epoch and a 20-s infusion epoch. Background was subtracted from the nadir during the baseline epoch. After conducting chemometric analyses, the average DA concentrations during the two epochs were compared.
Histology
After the completion of each experiment, subjects were euthanized with CO2 according to Institutional Animal Care and Use Committee guidelines. To verify placements of voltammetry recordings, small electrolytic lesions were created by running a current (250 μA) through a stainless steel electrode placed at the depth at which the recording took place. Brains were then removed and submerged in 10% formaldehyde for 14 days. All brains were then sliced into 40-μm sections, mounted, stained with 0.25% thionin, and coverslipped.
Statistical analysis
In the cocaine experiment, time-averaged DA concentrations, transient frequency, half-width, and amplitude were analyzed with four separate 2 (group: corticosterone vs. vehicle) × 3 (phase: baseline vs. treatment vs. cocaine) mixed anovas followed by planned contrasts to determine whether DA is elevated during the treatment phase (relative to baseline) and again during the cocaine phase (relative to the treatment phase). In the saccharin experiment, time-averaged DA concentrations were analyzed with a 2 (epoch: baseline vs. infusion) × 2 (phase: pre-vs. post-corticosterone) within-subjects anova. Statistical analyses were performed using Statistica 6.0 (Stat Soft).
Results
Corticosterone and cocaine interacted to increase extracellular DA in the NAc
In the first experiment, potential interactions between cocaine and corticosterone in the regulation of overall DA concentration were assessed in the NAc core and shell. Figure [NaN] depicts the experimental design and time-averaged DA concentration (average color plots) from representative corticosterone-and vehicle-treated rats across the three experimental phases. A comparison of core (n = 4) and shell (n = 6) electrode placements in corticosterone-treated rats showed an effect of phase, F2,16 = 23.54, P < 0.001, but no effect of placement, Fig. [NaN] A) . Therefore, core and shell data were collapsed in subsequent analyses. Corticosterone appeared to cause an elevation in average DA concentration, and only corticosterone-treated rats exhibited an increase in DA concentration after the injection of cocaine (see Fig. [NaN] B) . anova revealed an effect of phase, F2,30 = 13.92, P < 0.001, and a group × phase interaction, F2,30 = 12.62, P < 0.001, but no effect of group, F1,15 = 1.15, P = 0.30. Planned contrasts showed that corticosterone elevated DA above baseline levels, F1,15 = 9.95, P < 0.007, and cocaine further elevated DA above the level observed with corticosterone alone, F1,15 = 33.82, P < 0.001. Vehicle injections produced no elevation of DA above baseline, F1,15 = 3.03, P = 0.10, and cocaine alone produced no elevation relative to the vehicle phase, F1,15 = 0.91, P = 0.36. Although the latter null result may seem counterintuitive, the low dose of cocaine administered here does not facilitate reinstatement of cocaine seeking and does not increase DA as measured by microdialysis (Graf et al., [ 21] ). Corticosterone selectively affected measures of DA uptake Next, the characteristics of spontaneous DA transient release events were scrutinized to determine whether corticosterone preferentially affected release or uptake. Figure [NaN [ 53] ). anovas were conducted to examine each characteristic. An analysis of transient amplitude revealed an effect of phase, F2,30 = 8.94, P < 0.001, and a group × phase interaction, F2,30 = 5.80, P < 0.008, but no effect of group, F1,15 = 2.43, P = 0.14 (see Fig. [NaN] B) . Similar to the pattern observed in the time-averaged concentration data, transient amplitude was augmented by corticosterone, F1,15 = 9.86, P < 0.007, and further elevated by cocaine, F1,15 = 11.51, P < 0.005. No similar effects were observed in the vehicle condition, Fs < 3.6, Ps > 0.07. The analysis of transient half-width showed an effect of phase, F2,30 = 51.34, P < 0.001, and a group x phase interaction, F2,30 = 21.37, P < 0.001, but no effect of group, F1,15 = 4.33, P > 0.054 (see Fig. [NaN] C). As with time-averaged concentration and transient amplitude, transient half-width was increased by corticosterone, F1,15 = 24.75, P < 0.001, and further increased by cocaine F1,15 = 68.39, P < 0.001. Vehicle produced no effect, F1,15 = 0.41, P = 0.53, but cocaine did have an effect on halfwidth after vehicle injection, F1,15 = 6.36, P < 0.03. This increase in half-width seems to be relatively weak, as it is not reflected in the time-average DA concentration measurement. However, the corticosterone group exhibited longer transients than the vehicle group during the cocaine phase, F1,15 = 17.72, P < 0.001, showing that corticosterone potentiated the effect that cocaine normally has on half-width. In contrast, the frequency of transient release events was unaffected by corticosterone, vehicle, or cocaine, Fs < 2.68, Ps > 0.08 (see Fig. [NaN] D) , suggesting that DA neuron activity was not generally excited by administration of either corticosterone or cocaine. Thus, corticosterone and cocaine selectively inflated measures that are sensitive to reductions in DA clearance, but had no appreciable effect on the number of release events.
Corticosterone did not affect the DA response to gustatory rewards Finally, because corticosterone alone had an effect on DA signaling, and because past microdialysis studies have indicated that exogenous corticosterone increases DA levels in the NAc particularly during feeding (Piazza et al., [ 39] ), we examined the possibility that the steroid would modulate the DA response to saccharin, an appetitive natural reward. Figure [NaN] A shows the timing of events for each rat in the saccharin experiment. An intraoral saccharin infusion normally produces a phasic DA release in the NAc shell (see Fig. [NaN] B; Roitman et al., [ 42] ; Wheeler et al., [ 56] , [ 57] ). Here, naturally rewarding saccharin produced a phasic increase in DA that was unaffected by corticosterone administration (Fig. [NaN] C and D) . anova revealed an effect of epoch, F1,4 = 14.84, P < 0.02, but no other effect or interaction, Fs < 0.10, Ps > 0.77. Figure [NaN 
Discussion
Microdialysis studies have demonstrated that stress and glucocorticoids can increase DA in the NAc and augment the effect of cocaine on DA concentration, but mechanistic insight into how this occurs has been lacking (Piazza et al., [ 39] ; Graf et al., [ 21] ). Using fast-scan cyclic voltammetry in behaving rats, we found that a physiologically relevant injection of corticosterone selectively increases the amplitude and duration of spontaneous DA release events, and markedly augments cocaine's effect on those measures. These observations provide unique insight into the mechanisms by which corticosterone and cocaine interact to influence DA signaling during moment-to-moment behavior.
The effect of corticosterone on spontaneous DA signaling There are at least two mechanisms by which corticosterone might enhance DA signaling in the NAc. First, corticosterone can act in the ventral tegmental area (VTA) to increase the sensitivity of VTA neurons to glutamatergic signaling. Specifically, corticosterone has been shown to lower NMDA excitatory thresholds in the VTA (Berry et al., [ 5] ), and to augment spontaneous neural firing in the presence of AMPA or NMDA through a non-genomic mechanism under temporal parameters similar to those used in the present studies (Cho & Little, [ 10] ). However, it is unlikely that an increase in glutamate sensitivity in DA neurons would selectively affect transient amplitude and duration, but not frequency. In fact, NMDA in the VTA induces burst firing in DA neurons (Chergui et al., [9] ), and NMDA receptor antagonism explicitly reduces transient frequency in the NAc (Sombers et al., [ 46] ). Thus, although there may be situations in which corticosterone can alter glutamate sensitivity in VTA neurons, it is unlikely that changes in DA neuron sensitivity to glutamate are responsible for the results observed here.
Instead, the pattern of results suggests that corticosterone is acting locally in the NAc to interfere with DA uptake mechanisms. We have previously demonstrated that corticosterone can potentiate cocaine-primed reinstatement of drug seeking even when infused directly into the NAc, supporting the hypothesis that it acts locally in DA terminal regions to potentiate the effects of cocaine on DA (Graf et al., [ 21] ). One likely mechanism of action is corticosterone's blockade of uptake2-mediated DA clearance in the NAc (Iversen & Salt, [ 27] ). Recent studies specifically implicate organic cation transporter 3 (OCT3), an uptake2 transporter inhibited by corticosterone at physiological concentrations (Gasser et al., [17] ; Hill et al., [ 24] ), in the ability of stress and corticosterone to potentiate cocaine-primed reinstatement. These studies demonstrate: (i) that corticosterone decreases DA transporter-independent DA clearance in the NAc of anesthetized rats; and (ii) that mice genetically engineered to lack OCT3-mediated transport (Wultsch et al., [ 60] ) do not exhibit the corticosteroneinduced potentiation of cocaine-primed reinstatement that is observed in wild-type mice (McReynolds et al., [ 37] ). Considering this convergent evidence, it is likely that the effects of corticosterone on DA transients observed in the current studies are due to local actions of the hormone in the NAc to block OCT3-mediated DA clearance, resulting in prolonged DA transients that are further lengthened by cocaine's actions on the DA transporter.
The effect of corticosterone and cocaine on spontaneous DA signaling This is the first description of an interaction between corticosterone and cocaine in the regulation of subsecond DA signaling in awake and behaving animals. Previous studies have reported that cocaine alone boosts transient frequency, amplitude, and duration, particularly in the shell of the NAc (Stuber et al., [ 49] ; Aragona et al., [ 1] ). Aragona et al. ([ 1] ) found that cocaine increased transient amplitude and half-width equally in the core and shell regions, but preferentially increased transient frequency in the shell subregion. This core/shell difference could be facilitated by corticosterone, as microdialysis experiments have shown that cocaine-induced DA concentration increases in the shell, but not the core, require endogenous corticosterone (Barrot et al., [ 2] ). In contrast, we found that a comparatively low dose of cocaine, when combined with corticosterone, increased transient amplitude and half-width in the core and shell regions, but did not affect frequency in either region. As stated above, this suggests that the low dose of cocaine, combined with corticosterone, is not likely acting in the VTA to increase DA neuron burst firing rates, but instead selectively regulating DA clearance. Based on the previous findings, a larger dose of cocaine would almost certainly preferentially boost DA in the shell and increase transient frequency either through a pre-synaptic mechanism or through disinhibitory NAc feedback to the VTA (Aragona et al., [ 1] ; Bocklisch et al., [ 7] ). Perhaps not coincidentally, sensitivity to the rewarding effects of cocaine at higher doses is less affected by stress or the administration of exogenous corticosterone (Goeders & Guerin, [ 18] ; Mantsch & Goeders, [ 30] ).
The effect of corticosterone on saccharin-induced DA release Although corticosterone had a clear synergistic relationship with cocaine, it had no effect on the DA response to the natural gustatory reward, saccharin. This indicates that corticosterone can differentially affect the processing of natural and drug rewards. This finding is somewhat surprising because stress and glucocorticoids can increase the consumption of palatable foods (Rowland & Antelman, [ 44] ; Dallman et al., [ 14] ; Dallman, [ 13] ), and previous studies have found that corticosterone facilitates consumption of and appetitive responses to saccharin (Silva, [ 45] ; Bhatnagar et al., [ 6] ), which presumably would be reflected in DA signaling. However, there are factors to consider that may explain why corticosterone selectively affected the DA response to cocaine. In studies describing a reduction of saccharin consumption or palatability in adrenalectomized rats, there is no evidence of enhanced saccharin consumption or palatability in situations in which corticosterone is elevated above normal levels. That is, there may be a certain level of circulating corticosterone that is required for normal saccharin palatability, but elevations beyond that threshold do not augment palatability. Additionally, we are not aware of studies demonstrating that acute stress or glucocorticoid administration enhance the palatability or consumption of saccharin in intact rats, and they may even decrease motivation to consume saccharin (Plaznik et al., [ 40] ; Howell et al., [ 25] ). It is likely that DA signaling would be dramatically altered in animals with low corticosterone levels, as DA flexibly tracks reward value (Wheeler et al., [56] , [ 57] ; McCutcheon et al., [ 36] ; Cone et al., [ 11] ), but it is unaffected in healthy animals in which corticosterone can fluctuate naturally.
Finally, it is important to note that stress and glucocorticoids could potentiate DA responses to natural rewards under different conditions. Many studies that observe an increase in eating due to stress or glucocorticoids involve repeated exposures to stress, stress hormones, and calorically dense food (Dallman et al., [ 14] ; Dallman, [ 13] ; Sominsky & Spencer, [ 47] ). This sort of experience could produce changes in how stress and food stimuli interact neurologically based on homeostatic pressures or learned compensatory or prophylactic behaviors (Pecoraro et al., [ 38] ; Ulrich-Lai et al., [ 52] ; Liang et al., [ 29] ). In the present study, the exposure to corticosterone was acute, saccharin is palatable but non-caloric, and there was no opportunity for subjects to learn any association between food consumption and the stress response. In other situations, glucocorticoids can stimulate appetite through many physiological pathways (Sominsky & Spencer, [ 47] ), but the present results suggest that the critical appetite-inducing action of corticosterone is not likely to be a selective reduction of DA clearance in the NAc.
Conclusion
Stress and the cascade of physiological events that it induces have a profound effect on motivated behavior. This leaves open the possibility that stress-induced glucocorticoid release influences DA responses to drugs of abuse and natural rewards via a common pathway. Here, we observed that one potential mechanism, corticosterone's impact on DA clearance, boosts the increase in extracellular DA caused by cocaine, but does not affect the DA response to a natural reward. The results reveal a corticosterone-sensitive DA clearance mechanism that, in concert with the DA transporter, contributes to the regulation of dopaminergic neurotransmission in the NAc and may underlie stress and glucocorticoid influences on cocaine-seeking behavior.
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